Marion Boldingh

  • Postdoc, senior consultant; PhD
 

Publications 2024

Gilhus NE, Andersen H, Andersen LK, Boldingh M, Laakso S, Leopoldsdottir MO, Madsen S, Piehl F, Popperud TH, Punga AR, Schirakow L, Vissing J (2024)
Generalized myasthenia gravis with acetylcholine receptor antibodies: A guidance for treatment
Eur J Neurol, 31 (5), e16229
DOI 10.1111/ene.16229, PubMed 38321574

Leone MA, Helbok R, Bianchi E, Yasuda CL, Konti M, Ramankulov D, Lolich M, Lovrencic-Huzjan A, Kovács T, Armon C, Cotelli MS, Cavallieri F, Grosu O, Kiteva-Trenchevska G, Rodriguez-Leyva I, Boldingh M, Brola W, Maia LF, de Seabra MML, Davidescu EI, Popescu BO, Kopishinskaia S, Bassetti CLA, Moro E, ENERGY Study Group (§) (2024)
Outcome predictors of post-COVID conditions in the European Academy of Neurology COVID-19 registry
J Neurol, 271 (6), 3153-3168
DOI 10.1007/s00415-024-12212-8, PubMed 38436682

Publications 2012

Maniaol AH, Boldingh M, Brunborg C, Harbo HF, Tallaksen CME (2012)
Smoking and socio-economic status may affect myasthenia gravis
Eur J Neurol, 20 (3), 453-460
DOI 10.1111/j.1468-1331.2012.03843.x, PubMed 22934661

Page visits: 347